Sands Capital Ventures, LLC
Q4 2024 13F Holdings
- Locationarlington, VA
- Num holdings
21
- Value ($000)
$459,729
- Date Filed02/13/2025
- Form type13F-HR
- CIK0001846444
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KVYO KLAVIYO INC | COM SER A | 49845K101 | $143.13 M | 31 % | 3,470,694 | ||
NU NU HLDGS LTD | ORD SHS CL A | G6683N103 | $72.74 M | 16 % | 7,021,159 | ||
DASH DOORDASH INC | CL A | 25809K105 | $68.33 M | 15 % | 407,343 | ||
IKT INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | $35.59 M | 8 % | 10,950,000 | ||
CPNG COUPANG INC | CL A | 22266T109 | $20.33 M | 4 % | 924,712 | ||
UIPATH INC | CL A | 90364P105 | $20.14 M | 4 % | 1,584,677 | ||
DDOG DATADOG INC | CL A COM | 23804L103 | $13.97 M | 3 % | 97,788 | ||
ACRV ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | $12.78 M | 3 % | 2,122,605 | ||
MONDAY COM LTD | SHS | M7S64H106 | $11.37 M | 3 % | 48,278 | ||
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $9.41 M | 2 % | 170,000 |
Rows Per Page
10
- 10
- 50
- 100